M3258

M3258 · EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M3258, covering 2023-03-24 to 2023-03-24. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Dose Escalation of M3258 as a Single Agent and Expansion Study of M3258 in Combination With Dexamethasone [Phase 1]

See pricing